Gastro-intestinal system | |||||
---|---|---|---|---|---|
Gastro-intestinal system / Diarrhoea | |||||
codeine phosphate | On Formulary | ||||
CODEINE PHOSPHATE
Chronic diarrhoea in children >12years without any respiratory issues |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Paediatric Acute Sickle Cell Pain Pathway
See attached |
|||||
Paediatric Acute Pain Pathway
See attached |
|||||
loperamide hydrochloride | On Formulary | ||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
|
|||||
LOPERAMIDE HYDROCHLORIDE
For chronic diarrhoea, irritable bowel where diarrhoea is predominant, and Short Bowel Syndrome |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Orodispersible tablet | |||||
Imodium (McNeil Products Ltd) | On Formulary | ||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
Gastro-intestinal system / Exocrine pancreatic insufficiency | |||||
pancreatin | On Formulary | ||||
Gastro-resistant capsule | |||||
Creon (Viatris UK Healthcare Ltd) | On Formulary | ||||
Gastro-resistant granules | |||||
Creon (Viatris UK Healthcare Ltd) | On Formulary | ||||
Gastro-intestinal system / Obesity | |||||
orlistat | On Formulary | ||||
Orlistat Use in Childhood Obesity June 2015
|
|||||
Gastro-intestinal system / Inflammatory bowel disease | |||||
Vedolizumab | Hospital Only | ||||
Paediatric Ulcerative Colitis aged 3-18yrs
4th line treatment for paediatric ulcerative colitis (see attached algorithm below)
IV infusion loading dose 6mg/kg (max dose 300mg) at week 0, 2 and 6 then maintenance every 8 weeks. Blueteq form required for post-pubescent patients - check paediatric gastroenterology pharmacist is aware of all new patients starting treatment.
|
|||||
Paediatric Crohn's Disease
Post-pubescent patients only - Blueteq form required. Dosing as for ulcerative colitis. |
|||||
adalimumab | On Formulary |
NICE TA373 NICE TA455 |
|||
ADALIMUMAB
Acute Crohn's disease in combination with Methotrexate or Azathioprine |
|||||
azathioprine | Hospital Only | ||||
Difficult to Obtain Letter
see attached |
|||||
AZATHIOPRINE
CYTOTOXIC- tablets should not be broken, crushed or dissolved |
|||||
balsalazide sodium | On Formulary | ||||
BALSALAZIDE SODIUM | |||||
beclometasone dipropionate | On Formulary | ||||
budesonide | On Formulary | ||||
Budesonide Oral Viscous - For Eosinophilic Oesophagitis
Use budesonide nebuliser solution according to guidelines attached. |
|||||
ciclosporin | On Formulary | ||||
CICLOSPORIN
For Hospital Use Only |
|||||
CICLOSPORIN
Ciclosporin - last line for Ulcerative Colitis not responsive to aminosalicylates & corticosteroids |
|||||
Solution for infusion | |||||
Sandimmun (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
Sandimmun®
For Hospital Use Only - Unless part of SCG |
|||||
golimumab | Off Formulary | ||||
hydrocortisone | On Formulary | ||||
HYDROCORTISONE
|
|||||
infliximab | On Formulary |
NICE TA187 NICE TA329 |
|||
Use of Infliximab in Inflammatory Bowel Disorders
see attached |
|||||
Bart's Health - Guidance for use of Infliximab
see attached |
|||||
INFLIXIMAB
Severe active Ulcerative Colitis/Crohn's disease |
|||||
mercaptopurine | On Formulary | ||||
MERCAPTOPURINE
CYTOTOXIC- tablets should not be broken, crushed or dissolved |
|||||
mesalazine | On Formulary | ||||
Drugs Used in Paediatric Inflammatory Bowel Disease
|
|||||
MESALAZINE
*Specify preparation by brand name* |
|||||
Gastro-resistant tablet | |||||
Salofalk (Dr. Falk Pharma UK Ltd) | On Formulary | ||||
NICE Guidance
*Specify preparation by brand name* |
|||||
Modified-release granules | |||||
Pentasa (Ferring Pharmaceuticals Ltd) | On Formulary | ||||
NICE Guidance
*Specify preparation by brand name* |
|||||
Salofalk (Dr. Falk Pharma UK Ltd) | On Formulary | ||||
NICE Guidance
*Specify preparation by brand name* |
|||||
Suppository | |||||
Pentasa (Ferring Pharmaceuticals Ltd) | On Formulary | ||||
NICE Guidance
*Specify preparation by brand name* |
|||||
Salofalk (Dr. Falk Pharma UK Ltd) | On Formulary | ||||
NICE Guidance
*Specify preparation by brand name* |
|||||
methotrexate | On Formulary | ||||
Methotrexate
Hospital Use Only |
|||||
Monitoring blood values while on methotrexate
see attached |
|||||
Methotrexate Blood Monitoring Schedule
see attached |
|||||
METHOTREXATE
*ONCE WEEKLY dosing* |
|||||
prednisolone | On Formulary | ||||
Cystic Fibrosis & non-CF Prescribing Pathway
see attached |
|||||
PREDNISOLONE
https://pathways.nice.org.uk/pathways/ulcerative-colitis https://pathways.nice.org.uk/pathways/crohns-disease
|
|||||
Prednisolone soluble tablets
Non-formulary (except long term patients with compliance issues) |
|||||
sulfasalazine | On Formulary | ||||
SULFASALAZINE
Chronic bowel disorders (Ulcerative Colitis/ Crohn's disease) https://pathways.nice.org.uk/pathways/ulcerative-colitis
|
|||||
Gastro-resistant tablet | |||||
Sulfasalazine (Non-proprietary) | On Formulary | ||||
NICE Guidance
Chronic bowel disorders (Ulcerative Colitis/ Crohn's disease) |
|||||
Oral suspension | |||||
Sulfasalazine (Non-proprietary) | On Formulary | ||||
NICE Guidance
Chronic bowel disorders (Ulcerative Colitis/ Crohn's disease) |
|||||
ustekinumab | Hospital Only |
NICE TA455 |
|||
Paediatric Crohn’s disease aged 3-18yrs
4th line treatment (see attached algorithm below) IV infusion loading dose 6mg/kg at week 0, followed by 8 weekly subcutaneous injection 45 mg (≤ 45kg) or 90 mg (>45kg) – weight dependent
DTC DEC 2021 Approval recevied to increase dosing frequency- schedule to 6 weekly for 1 patient/year and 4 weekly for 1 patient every 2 years |
|||||
July 2024 - Ustekinumab for refractory Crohn’s disease in pre-pubescent children
The licence has been extened for ustekinumab in children aged 6 years and over for paediatric plaque psoriasis, application of the Commissioning Medicines for Children policy also enables access to children aged 6 years and over with Crohn’s disease. |
|||||
Gastro-intestinal system / Irritable bowel syndrome | |||||
mebeverine hydrochloride | On Formulary | ||||
Modified-release capsule | |||||
Colofac MR (Viatris UK Healthcare Ltd) | On Formulary | ||||
Oral suspension | |||||
Mebeverine hydrochloride (Non-proprietary) | On Formulary | ||||
peppermint oil | On Formulary | ||||
Modified-release capsule | |||||
Colpermin (Johnson & Johnson Ltd) | On Formulary | ||||
Gastro-intestinal system / Bowel cleansing | |||||
bisacodyl | On Formulary | ||||
Barts Health Guideline - Management of Constipation in Children
|
|||||
Difficult to Obtain Letter
|
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
BISACODYL
|
|||||
Gastro-resistant tablet | |||||
Bisacodyl (Non-proprietary) | On Formulary | ||||
docusate sodium | On Formulary | ||||
Paediatric Oncology Local Guidelines July 14
|
|||||
Barts Health Guideline - Management of Constipation in Children
|
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
DOCUSATE SODIUM
|
|||||
Oral solution | |||||
Docusol (Typharm Ltd) | On Formulary | ||||
Paediatric Oncology Local Guidelines July 14
|
|||||
The Association of Paediatric Palliative Medicine Formulary - 2015
|
|||||
Barts Health Guideline - Management of Constipation in Children
|
|||||
macrogol 3350 with anhydrous sodium sulfate, potassium chloride, sodium bicarbonate and sodium chloride | On Formulary | ||||
Barts Health Bowel Cleansing guidelines
BH Bowel Cleansing guidelines |
|||||
Bowel Cleansing
Bowel Cleansing |
|||||
magnesium citrate with sodium picosulfate | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
meglumine amidotrizoate with sodium amidotrizoate | On Formulary | ||||
Oral solution | |||||
Gastrografin (Bayer Plc) | On Formulary | ||||
Gastro-intestinal system / Constipation | |||||
bisacodyl | On Formulary | ||||
Barts Health Guideline - Management of Constipation in Children
|
|||||
Difficult to Obtain Letter
|
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
BISACODYL
|
|||||
Gastro-resistant tablet | |||||
Bisacodyl (Non-proprietary) | On Formulary | ||||
docusate sodium | On Formulary | ||||
Paediatric Oncology Local Guidelines July 14
|
|||||
Barts Health Guideline - Management of Constipation in Children
|
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
DOCUSATE SODIUM
|
|||||
Oral solution | |||||
Docusol (Typharm Ltd) | On Formulary | ||||
Paediatric Oncology Local Guidelines July 14
|
|||||
The Association of Paediatric Palliative Medicine Formulary - 2015
|
|||||
Barts Health Guideline - Management of Constipation in Children
|
|||||
glycerol | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
GLYCEROL
|
|||||
Suppository | |||||
Glycerol (Non-proprietary) | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
|
|||||
ispaghula husk | On Formulary | ||||
ISPAGHULA HUSK
Irritable Bowel Syndrome if increased dietary fibre is required |
|||||
lactulose | On Formulary | ||||
Paediatric Oncology Local Guidelines July 14
|
|||||
Barts Health Guideline - Management of Constipation in Children
|
|||||
Cystic Fibrosis & non-CF Prescribing Pathway
|
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
LACTULOSE
https://www.nice.org.uk/guidance/cg99 |
|||||
Oral solution | |||||
Lactulose (Non-proprietary) | On Formulary | ||||
Paediatric Oncology Local Guidelines July 14
see attached |
|||||
Barts Health Guideline - Management of Constipation in Children
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
macrogol 3350 with potassium chloride, sodium bicarbonate and sodium chloride | On Formulary | ||||
senna | On Formulary | ||||
Paediatric Oncology Local Guidelines July 14
|
|||||
Barts Health Guideline - Management of Constipation in Children
|
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see link |
|||||
SENNA
|
|||||
sodium picosulfate | On Formulary | ||||
Paediatric Oncology Local Guidelines July 14
|
|||||
Barts Health Guideline - Management of Constipation in Children
|
|||||
Paediatric Oncology Local Guidelines July 14
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
SODIUM PICOSULFATE
|
|||||
Oral solution | |||||
Sodium picosulfate (Non-proprietary) | On Formulary | ||||
Paediatric Oncology Local Guidelines July 14
|
|||||
Barts Health Guideline - Management of Constipation in Children
see attached |
|||||
Gastro-intestinal system / Food allergy | |||||
chlorphenamine maleate | On Formulary | ||||
Oral solution | |||||
Chlorphenamine maleate (Non-proprietary) | On Formulary | ||||
Paediatric Oncology Local Guidelines July 14
see attached |
|||||
sodium cromoglicate | On Formulary | ||||
Gastro-intestinal system / Gastro-intestinal smooth muscle spasm | |||||
dicycloverine hydrochloride | On Formulary | ||||
Oral solution | |||||
Dicycloverine hydrochloride (Non-proprietary) | On Formulary | ||||
hyoscine butylbromide | On Formulary | ||||
HYOSCINE BUTYLBROMIDE
Hyoscine butylbromide oral doses commonly used at Barts Health: |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Solution for injection | |||||
Buscopan (Sanofi Consumer Healthcare) | On Formulary | ||||
mebeverine hydrochloride | On Formulary | ||||
Modified-release capsule | |||||
Colofac MR (Viatris UK Healthcare Ltd) | On Formulary | ||||
Oral suspension | |||||
Mebeverine hydrochloride (Non-proprietary) | On Formulary | ||||
Gastro-intestinal system / Biliary disorders | |||||
cholic acid | Hospital Only | ||||
colestyramine | On Formulary | ||||
COLESTYRAMINE
Diarrhoea resulting from the loss of bile-salt absorption |
|||||
ursodeoxycholic acid | On Formulary | ||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
|
|||||
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
URSODEOXYCHOLIC ACID
Short Bowel Syndrome |
|||||
Oral suspension | |||||
Ursofalk (Dr. Falk Pharma UK Ltd) | On Formulary | ||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
Gastro-intestinal system / Hepatic encephalopathy | |||||
lactulose | On Formulary | ||||
Paediatric Oncology Local Guidelines July 14
|
|||||
Barts Health Guideline - Management of Constipation in Children
|
|||||
Cystic Fibrosis & non-CF Prescribing Pathway
|
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
LACTULOSE
https://www.nice.org.uk/guidance/cg99 |
|||||
Oral solution | |||||
Lactulose (Non-proprietary) | On Formulary | ||||
Paediatric Oncology Local Guidelines July 14
see attached |
|||||
Barts Health Guideline - Management of Constipation in Children
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
Gastro-intestinal system / Oesophageal varices | |||||
terlipressin acetate | On Formulary | ||||
For Hospital Use Only
|
|||||
Solution for injection | |||||
Terlipressin acetate (Non-proprietary) | On Formulary | ||||
Glypressin®
For Hospital Use Only |
|||||
vasopressin | On Formulary | ||||
Synthetic vasopressin
Injection Formulation is Hospital Use Only |
|||||
Solution for injection | |||||
Vasopressin (Non-proprietary) | On Formulary | ||||
Note
Injection Formulation is Hospital Use Only |
|||||
Gastro-intestinal system / Dyspepsia | |||||
magnesium trisilicate with magnesium carbonate and sodium bicarbonate | On Formulary | ||||
MAGNESIUM TRISILICATE
For primary care only |
|||||
sodium alginate with potassium bicarbonate | |||||
Oral suspension | |||||
Gaviscon Advance (Reckitt Benckiser Healthcare (UK) Ltd) | On Formulary | ||||
Cystic Fibrosis & non-CF Prescribing Pathway
CF & non CF Prescribing Pathway |
|||||
Gaviscon® Advance
For use in Primary care only |
|||||
Gastro-intestinal system / Gastric and duodenal ulceration | |||||
esomeprazole | Off Formulary | ||||
Gastro-resistant tablet | |||||
Esomeprazole (Non-proprietary) | Off Formulary | ||||
Nexium (Grunenthal Ltd, Haleon UK Trading Ltd) | Off Formulary | ||||
Gastro-resistant capsule | |||||
Esomeprazole (Non-proprietary) | Off Formulary | ||||
Emozul (Krka UK Ltd) | Off Formulary | ||||
Powder for solution for injection | |||||
Esomeprazole (Non-proprietary) | Off Formulary | ||||
Nexium (Grunenthal Ltd) | Off Formulary | ||||
lansoprazole | On Formulary | ||||
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
Cystic Fibrosis & non-CF Prescribing Pathway
|
|||||
Barts Health Oral Proton Pump Inhibitor use in Children Guideline
|
|||||
LANSOPRAZOLE
https://pathways.nice.org.uk/pathways/acute-upper-gastrointestinal-bleeding |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Orodispersible tablet | |||||
Zoton FasTab (Pfizer Ltd) | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
|
|||||
Barts Health Oral Proton Pump Inhibitor use in Children Guideline
|
|||||
Zoton®
Alternative to lansoprazole capsules |
|||||
omeprazole | On Formulary | ||||
Barts Health Paediatric H pylori eradication Guideline
Seek advice from tertiary Paediatric Gastro team before initiating H pylori eradication treatment. |
|||||
Barts Health Oral Proton Pump Inhibitor use in Children Guideline
|
|||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
|
|||||
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
Cystic Fibrosis & non-CF Prescribing Pathway
|
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
OMEPRAZOLE
For NICE guidance on management of upper GI bleeding in children over 16 years: https://pathways.nice.org.uk/pathways/acute-upper-gastrointestinal-bleeding |
|||||
ranitidine | On Formulary | ||||
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
RANITIDINE
First line for gastro-oesophageal reflux disease |
|||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
Cystic Fibrosis & non-CF Prescribing Pathway
see attached |
|||||
RANITIDINE
First line for gastro-oesophageal reflux disease |
|||||
Ranitidine Shortage Nov 2019
Please see memo for management during shortage at Barts Health |
|||||
sucralfate | On Formulary | ||||
SUCRALFATE
Last line for haematemesis despite optimal treatment with other drugs |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Gastro-intestinal system / Gastro-oesophageal reflux disease | |||||
esomeprazole | Off Formulary | ||||
ESOMEPRAZOLE
Only the injection formulation is on formulary, and is restricted for use in Paediatrics. |
|||||
Barts Health Oral Proton Pump Inhibitor use in Children Guideline
see attached |
|||||
Gastro-resistant tablet | |||||
Esomeprazole (Non-proprietary) | Off Formulary | ||||
Nexium (Grunenthal Ltd, Haleon UK Trading Ltd) | Off Formulary | ||||
Gastro-resistant capsule | |||||
Esomeprazole (Non-proprietary) | Off Formulary | ||||
Emozul (Krka UK Ltd) | Off Formulary | ||||
Powder for solution for injection | |||||
Esomeprazole (Non-proprietary) | Off Formulary | ||||
Esomeprazole
Only the injection formulation is on formulary, and is restricted for use in Paediatrics. |
|||||
Barts Health Oral Proton Pump Inhibitor use in Children Guideline
see attached |
|||||
Nexium (Grunenthal Ltd) | Off Formulary | ||||
lansoprazole | On Formulary | ||||
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
Cystic Fibrosis & non-CF Prescribing Pathway
|
|||||
Barts Health Oral Proton Pump Inhibitor use in Children Guideline
|
|||||
LANSOPRAZOLE
https://pathways.nice.org.uk/pathways/acute-upper-gastrointestinal-bleeding |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Orodispersible tablet | |||||
Zoton FasTab (Pfizer Ltd) | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
|
|||||
Barts Health Oral Proton Pump Inhibitor use in Children Guideline
|
|||||
Zoton®
Alternative to lansoprazole capsules |
|||||
omeprazole | On Formulary | ||||
Barts Health Paediatric H pylori eradication Guideline
Seek advice from tertiary Paediatric Gastro team before initiating H pylori eradication treatment. |
|||||
Barts Health Oral Proton Pump Inhibitor use in Children Guideline
|
|||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
|
|||||
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
Cystic Fibrosis & non-CF Prescribing Pathway
|
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
OMEPRAZOLE
For NICE guidance on management of upper GI bleeding in children over 16 years: https://pathways.nice.org.uk/pathways/acute-upper-gastrointestinal-bleeding |
|||||
sodium alginate with calcium carbonate and sodium bicarbonate | |||||
Oral suspension | |||||
Sodium alginate with calcium carbonate and sodium bicarbonate (Non-proprietary) | On Formulary | ||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH |
|||||
Peptac (Teva UK Ltd) | On Formulary | ||||
Cystic Fibrosis & non-CF Prescribing Pathway
CF & non-CF Prescribing Pathway |
|||||
Peptac®
For primary care only |
|||||
Gastro-intestinal system / Rectal and anal disorders | |||||
diltiazem hydrochloride | On Formulary | ||||
Modified-release tablet | |||||
Diltiazem hydrochloride (Non-proprietary) | On Formulary | ||||
Retalzem (Kent Pharma (UK) Ltd) | On Formulary | ||||
Tildiem (Sanofi) | On Formulary | ||||
Tildiem Retard (Sanofi) | On Formulary |